369 related articles for article (PubMed ID: 31337271)
21. Modulation of Cardiovascular Function in Primary Hypertension in Rat by SKA-31, an Activator of
Kloza M; Baranowska-Kuczko M; Toczek M; Kusaczuk M; Sadowska O; Kasacka I; Kozłowska H
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450834
[TBL] [Abstract][Full Text] [Related]
22. Anti-inflammatory and anti-fibrotic effects of modafinil in nonalcoholic liver disease.
Choi S; Kim JA; Li H; Jo SE; Lee H; Kim TH; Kim M; Kim SJ; Suh SH
Biomed Pharmacother; 2021 Dec; 144():112372. PubMed ID: 34794237
[TBL] [Abstract][Full Text] [Related]
23. Naphtho[1,2-d]thiazol-2-ylamine (SKA-31), a new activator of KCa2 and KCa3.1 potassium channels, potentiates the endothelium-derived hyperpolarizing factor response and lowers blood pressure.
Sankaranarayanan A; Raman G; Busch C; Schultz T; Zimin PI; Hoyer J; Köhler R; Wulff H
Mol Pharmacol; 2009 Feb; 75(2):281-95. PubMed ID: 18955585
[TBL] [Abstract][Full Text] [Related]
24. Structural Determinants for the Selectivity of the Positive KCa3.1 Gating Modulator 5-Methylnaphtho[2,1-
Brown BM; Shim H; Zhang M; Yarov-Yarovoy V; Wulff H
Mol Pharmacol; 2017 Oct; 92(4):469-480. PubMed ID: 28760780
[TBL] [Abstract][Full Text] [Related]
25. K
Orfali R; AlFaiz A; Rahman MA; Lau L; Nam YW; Zhang M
Biomedicines; 2023 Jun; 11(7):. PubMed ID: 37509419
[TBL] [Abstract][Full Text] [Related]
26. Prominent role of KCa3.1 in endothelium-derived hyperpolarizing factor-type dilations and conducted responses in the microcirculation in vivo.
Wölfle SE; Schmidt VJ; Hoyer J; Köhler R; de Wit C
Cardiovasc Res; 2009 Jun; 82(3):476-83. PubMed ID: 19218287
[TBL] [Abstract][Full Text] [Related]
27. Preserved regulation of renal perfusion pressure by small and intermediate conductance KCa channels in hypertensive mice with or without renal failure.
Waeckel L; Bertin F; Clavreul N; Damery T; Köhler R; Paysant J; Sansilvestri-Morel P; Simonet S; Vayssettes-Courchay C; Wulff H; Verbeuren TJ; Félétou M
Pflugers Arch; 2015 Apr; 467(4):817-31. PubMed ID: 24903240
[TBL] [Abstract][Full Text] [Related]
28. KCa2.3 channel-dependent hyperpolarization increases melanoma cell motility.
Chantome A; Girault A; Potier M; Collin C; Vaudin P; Pagès JC; Vandier C; Joulin V
Exp Cell Res; 2009 Dec; 315(20):3620-30. PubMed ID: 19646982
[TBL] [Abstract][Full Text] [Related]
29. Endothelial Ca+-activated K+ channels in normal and impaired EDHF-dilator responses--relevance to cardiovascular pathologies and drug discovery.
Grgic I; Kaistha BP; Hoyer J; Köhler R
Br J Pharmacol; 2009 Jun; 157(4):509-26. PubMed ID: 19302590
[TBL] [Abstract][Full Text] [Related]
30. Improvement of endothelium-dependent vasodilations by SKA-31 and SKA-20, activators of small- and intermediate-conductance Ca2+ -activated K+ -channels.
Hasenau AL; Nielsen G; Morisseau C; Hammock BD; Wulff H; Köhler R
Acta Physiol (Oxf); 2011 Sep; 203(1):117-26. PubMed ID: 21362152
[TBL] [Abstract][Full Text] [Related]
31. Targeting the Small- and Intermediate-Conductance Ca-Activated Potassium Channels: The Drug-Binding Pocket at the Channel/Calmodulin Interface.
Cui M; Qin G; Yu K; Bowers MS; Zhang M
Neurosignals; 2014; 22(2):65-78. PubMed ID: 25300231
[TBL] [Abstract][Full Text] [Related]
32. Dynamic coupling between TRPV4 and Ca
Li Y; Hu H; Tian JB; Zhu MX; O'Neil RG
Am J Physiol Renal Physiol; 2017 Jun; 312(6):F1081-F1089. PubMed ID: 28274924
[TBL] [Abstract][Full Text] [Related]
33. New Insights on KCa3.1 Channel Modulation.
Manfroni G; Ragonese F; Monarca L; Astolfi A; Mancinelli L; Iannitti RG; Bastioli F; Barreca ML; Cecchetti V; Fioretti B
Curr Pharm Des; 2020; 26(18):2096-2101. PubMed ID: 32175839
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological activation of KCa3.1/KCa2.3 channels produces endothelial hyperpolarization and lowers blood pressure in conscious dogs.
Damkjaer M; Nielsen G; Bodendiek S; Staehr M; Gramsbergen JB; de Wit C; Jensen BL; Simonsen U; Bie P; Wulff H; Köhler R
Br J Pharmacol; 2012 Jan; 165(1):223-34. PubMed ID: 21699504
[TBL] [Abstract][Full Text] [Related]
35. Contribution of the KCa3.1 channel-calmodulin interactions to the regulation of the KCa3.1 gating process.
Morales P; Garneau L; Klein H; Lavoie MF; Parent L; Sauvé R
J Gen Physiol; 2013 Jul; 142(1):37-60. PubMed ID: 23797421
[TBL] [Abstract][Full Text] [Related]
36. Vascular KCa-channels as therapeutic targets in hypertension and restenosis disease.
Köhler R; Kaistha BP; Wulff H
Expert Opin Ther Targets; 2010 Feb; 14(2):143-55. PubMed ID: 20055714
[TBL] [Abstract][Full Text] [Related]
37. Evidence for functional and dynamic microcompartmentation of Cav-1/TRPV4/K(Ca) in caveolae of endothelial cells.
Goedicke-Fritz S; Kaistha A; Kacik M; Markert S; Hofmeister A; Busch C; Bänfer S; Jacob R; Grgic I; Hoyer J
Eur J Cell Biol; 2015; 94(7-9):391-400. PubMed ID: 26116074
[TBL] [Abstract][Full Text] [Related]
38. Subtype-Selective Positive Modulation of K
Nam YW; Pala R; El-Sayed NS; Larin-Henriquez D; Amirrad F; Yang G; Rahman MA; Orfali R; Downey M; Parang K; Nauli SM; Zhang M
ACS Chem Biol; 2022 Aug; 17(8):2344-2354. PubMed ID: 35947779
[TBL] [Abstract][Full Text] [Related]
39. The Trials and Tribulations of Structure Assisted Design of K
Shim H; Brown BM; Singh L; Singh V; Fettinger JC; Yarov-Yarovoy V; Wulff H
Front Pharmacol; 2019; 10():972. PubMed ID: 31616290
[TBL] [Abstract][Full Text] [Related]
40. Phosphatidylinositol 3-phosphate indirectly activates KCa3.1 via 14 amino acids in the carboxy terminus of KCa3.1.
Srivastava S; Choudhury P; Li Z; Liu G; Nadkarni V; Ko K; Coetzee WA; Skolnik EY
Mol Biol Cell; 2006 Jan; 17(1):146-54. PubMed ID: 16251351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
